Loading clinical trials...
Loading clinical trials...
Clinical Evaluation of Individuals With X-linked Retinitis Pigmentosa (XLRP) Caused by RPGR-ORF15 Mutations
Conditions
Locations
3
United States
Duke Eye Center, Duke University Medical Center
Durham, North Carolina, United States
Casey Eye Institute, Oregon Health and Sciences University
Portland, Oregon, United States
Retina Foundation of the Southwest
Dallas, Texas, United States
Start Date
December 1, 2017
Primary Completion Date
February 10, 2022
Completion Date
February 10, 2022
Last Updated
January 11, 2023
NCT07174726
NCT06492850
NCT06646289
NCT04850118
NCT04517149
Lead Sponsor
Beacon Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions